Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

I-arch in Action: Early Clinical Impact From a Randomized Controlled Trial

NCT07264127 is registered in ClinicalTrials.gov with Tabark H. Omran as lead sponsor.

NCT NCT07264127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07264127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
I-arch in Action: Early Clinical Impact From a Randomized Controlled Trial
Lead sponsor
Tabark H. Omran
Phase
Not applicable
Overall status
Recruiting
Start date
December 1, 2025
Completion date
September 30, 2026
Enrollment
34 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

effectiveness of the i-arch system